by CheckRare Staff | Feb 16, 2024
« Prev1 / 1Next »Subtypes of CTCL: Mycosis Fungoides and Sézary Syndrome (Full Interview)CTCL: Mycosis Fungoides and Sézary Syndrome Overview (Chapter 1)Diagnosis of Mycosis Fungoides and Sézary Syndrome (Chapter 2)Importance of Accurate Staging When...
by CheckRare Staff | Feb 16, 2024
Wei Ying Jen, MD, of the Department of Leukemia at the University of Texas MD Anderson Cancer Center, discusses Philadelphia chromosome-positive acute lymphoblastic leukemia and treatment options. Philadelphia chromosome (Ph)-positive acute lymphoblastic...
by CheckRare Staff | Feb 13, 2024
Jörg Schüttrumpf, MD, Chief Scientific Innovation Officer at Grifols, discusses the Phase 1/2 study evaluating a breakthrough treatment option for alpha1-antitrypsin deficiency. Alpha-1 antitrypsin deficiency (AATD) is an inherited disease caused by...
by CheckRare Staff | Feb 10, 2024
Jatin Shah, MD, PhD, of Sumitomo Pharma, discusses two treatments in Phase 1 trials for myelofibrosis and acute myeloid leukemia. Jatin Shah, MD, PhD, of Sumitomo Pharma, discusses two treatments in Phase 1 trials for myelofibrosis and acute myeloid...
by CheckRare Staff | Feb 9, 2024
Steven Pipe, MD, of the University of Michigan, discusses the results of HAVEN 7, a Phase 3 trial testing the efficacy and safety of emicizumab to prevent bleeding episodes in patients under 12 months of age with hemophilia A. Hemophilia A is a...
